nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone phenpropionate—CYP19A1—Paclitaxel—kidney cancer	0.803	1	CbGbCtD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—SYNE2—kidney cancer	0.014	0.0711	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CITED1—kidney cancer	0.00772	0.0393	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—ALDH1A1—kidney cancer	0.00573	0.0291	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.00558	0.0284	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—EIF4EBP1—kidney cancer	0.00509	0.0259	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00375	0.0191	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—ACY1—kidney cancer	0.00364	0.0185	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—EGR1—kidney cancer	0.00347	0.0177	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—kidney cancer	0.00289	0.0147	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—TSC2—kidney cancer	0.00276	0.014	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.00269	0.0137	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Endogenous sterols—POMC—kidney cancer	0.00264	0.0134	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—FOSL1—kidney cancer	0.00237	0.0121	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00207	0.0105	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—HIF1A—kidney cancer	0.00206	0.0105	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—FOSL1—kidney cancer	0.00204	0.0104	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Tryptophan metabolism—CYP1A1—kidney cancer	0.00203	0.0103	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—ALDH1A1—kidney cancer	0.00199	0.0101	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—RAF1—kidney cancer	0.00199	0.0101	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—kidney cancer	0.00198	0.0101	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—KDR—kidney cancer	0.00197	0.01	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—RAF1—kidney cancer	0.00191	0.00974	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MTOR—kidney cancer	0.00187	0.00951	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.00178	0.00909	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.00167	0.0085	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.00164	0.00836	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.00162	0.00825	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Ovarian Infertility Genes—CDKN1B—kidney cancer	0.00153	0.00779	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.00152	0.00773	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.00152	0.00773	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—IL13—kidney cancer	0.0015	0.00763	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.00144	0.00733	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK3—kidney cancer	0.00143	0.0073	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CD4—kidney cancer	0.00139	0.00708	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—ANXA1—kidney cancer	0.00139	0.00707	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.00139	0.00707	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK3—kidney cancer	0.00138	0.00702	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—CDKN1B—kidney cancer	0.00138	0.00702	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—MAPK1—kidney cancer	0.00137	0.00695	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.00135	0.00688	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00133	0.00678	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—FSH signaling pathway—MAPK1—kidney cancer	0.00131	0.00668	CbGpPWpGaD
Nandrolone phenpropionate—AR—FOXA1 transcription factor network—JUN—kidney cancer	0.00131	0.00668	CbGpPWpGaD
Nandrolone phenpropionate—AR—Notch-mediated HES/HEY network—CDKN1B—kidney cancer	0.00131	0.00665	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.00125	0.00637	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.00125	0.00635	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.00122	0.00623	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CDKN2A—kidney cancer	0.0012	0.0061	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—kidney cancer	0.00119	0.00608	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.00119	0.00608	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—kidney cancer	0.00119	0.00605	CbGpPWpGaD
Nandrolone phenpropionate—AR—Nongenotropic Androgen signaling—PIK3CA—kidney cancer	0.00118	0.00603	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTT1—kidney cancer	0.00117	0.00596	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.00116	0.00592	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.00115	0.00586	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.00114	0.00578	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of Androgen receptor activity—JUN—kidney cancer	0.00113	0.00575	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—PTGS1—kidney cancer	0.0011	0.00559	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—kidney cancer	0.00109	0.00557	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.00107	0.00546	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.00103	0.00526	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.00103	0.00526	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.00102	0.00521	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CCND1—kidney cancer	0.00101	0.00515	CbGpPWpGaD
Nandrolone phenpropionate—AR—Coregulation of Androgen receptor activity—CTNNB1—kidney cancer	0.001	0.0051	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000993	0.00505	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000968	0.00493	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000966	0.00492	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—kidney cancer	0.000965	0.00491	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HARS—kidney cancer	0.00093	0.00473	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000881	0.00448	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—RELA—kidney cancer	0.000852	0.00434	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000848	0.00432	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000841	0.00428	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000821	0.00418	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—kidney cancer	0.000815	0.00415	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—kidney cancer	0.000813	0.00414	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTP1—kidney cancer	0.000812	0.00413	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000809	0.00412	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—kidney cancer	0.000807	0.00411	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000805	0.0041	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTP1—kidney cancer	0.000801	0.00408	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EIF5B—kidney cancer	0.000791	0.00403	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.00079	0.00402	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CCND1—kidney cancer	0.000748	0.00381	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—JUN—kidney cancer	0.000747	0.0038	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—GSTM1—kidney cancer	0.000746	0.0038	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—CTNNB1—kidney cancer	0.000741	0.00377	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—GSTM1—kidney cancer	0.000736	0.00375	CbGpPWpGaD
Nandrolone phenpropionate—AR—Androgen receptor signaling pathway—PTEN—kidney cancer	0.000722	0.00368	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—CYP1A1—kidney cancer	0.000707	0.0036	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000698	0.00355	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000696	0.00354	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000672	0.00342	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000658	0.00335	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—kidney cancer	0.000654	0.00333	CbGpPWpGaD
Nandrolone phenpropionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000647	0.00329	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ACY1—kidney cancer	0.000622	0.00317	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000592	0.00301	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000578	0.00294	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000566	0.00288	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000548	0.00279	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000531	0.0027	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PDHB—kidney cancer	0.000529	0.00269	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Biological oxidations—POMC—kidney cancer	0.000527	0.00268	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—JUNB—kidney cancer	0.000513	0.00261	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EEF2—kidney cancer	0.00051	0.00259	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CCBL1—kidney cancer	0.000497	0.00253	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.00049	0.0025	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000489	0.00249	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TET2—kidney cancer	0.000489	0.00249	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000485	0.00247	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000477	0.00243	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000473	0.00241	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000473	0.00241	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.000471	0.0024	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000465	0.00237	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.00046	0.00234	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.00045	0.00229	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.00045	0.00229	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TCEB2—kidney cancer	0.000447	0.00227	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—TCEB1—kidney cancer	0.000447	0.00227	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PPAT—kidney cancer	0.000431	0.0022	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GLIPR1—kidney cancer	0.000431	0.0022	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000427	0.00218	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000426	0.00217	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000426	0.00217	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000422	0.00215	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000422	0.00215	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000421	0.00214	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000418	0.00213	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000418	0.00213	CbGpPWpGaD
Nandrolone phenpropionate—AR—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000416	0.00212	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000407	0.00207	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000406	0.00207	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000405	0.00206	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000402	0.00205	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—APRT—kidney cancer	0.000401	0.00204	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—FH—kidney cancer	0.000401	0.00204	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000393	0.002	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000392	0.002	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000392	0.00199	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000385	0.00196	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GPC3—kidney cancer	0.000377	0.00192	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.000368	0.00187	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CA2—kidney cancer	0.000367	0.00187	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000363	0.00185	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—RPL14—kidney cancer	0.000363	0.00185	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALAD—kidney cancer	0.000357	0.00182	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	0.000354	0.0018	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ST3GAL2—kidney cancer	0.000349	0.00178	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ALDH1A1—kidney cancer	0.000341	0.00174	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000338	0.00172	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	0.000335	0.00171	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	0.000331	0.00169	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PGK1—kidney cancer	0.000327	0.00166	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC5A3—kidney cancer	0.000327	0.00166	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	0.000326	0.00166	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000323	0.00164	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—LDHB—kidney cancer	0.000321	0.00163	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	0.000319	0.00162	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—kidney cancer	0.000313	0.00159	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	0.000301	0.00153	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—EIF4EBP1—kidney cancer	0.000296	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—HSPB1—kidney cancer	0.000296	0.00151	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CA9—kidney cancer	0.000278	0.00141	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Integrated Breast Cancer Pathway—TP53—kidney cancer	0.000278	0.00141	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	0.000277	0.00141	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—PSMD7—kidney cancer	0.000275	0.0014	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000272	0.00138	CbGpPWpGaD
Nandrolone phenpropionate—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	0.000268	0.00136	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—JUNB—kidney cancer	0.000247	0.00126	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CRABP1—kidney cancer	0.000236	0.0012	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ITPR2—kidney cancer	0.00022	0.00112	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000203	0.00103	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—CDKN2B—kidney cancer	0.000201	0.00102	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ACHE—kidney cancer	0.0002	0.00102	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTT1—kidney cancer	0.0002	0.00102	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SCARB1—kidney cancer	0.00019	0.000965	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS1—kidney cancer	0.000188	0.000956	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PSMD7—kidney cancer	0.000184	0.000937	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—BCHE—kidney cancer	0.000175	0.000888	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC5A5—kidney cancer	0.000172	0.000878	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—SLC2A1—kidney cancer	0.000166	0.000848	CbGpPWpGaD
Nandrolone phenpropionate—AR—Generic Transcription Pathway—MYC—kidney cancer	0.000162	0.000824	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000162	0.000822	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000141	0.000717	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTP1—kidney cancer	0.000139	0.000707	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—ABCB1—kidney cancer	0.000131	0.000669	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—GSTM1—kidney cancer	0.000128	0.00065	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—CYP1A1—kidney cancer	0.000121	0.000616	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.94e-05	0.000506	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—POMC—kidney cancer	9.02e-05	0.000459	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MAPK3—kidney cancer	8.01e-05	0.000408	CbGpPWpGaD
Nandrolone phenpropionate—AR—Gene Expression—MYC—kidney cancer	7.79e-05	0.000397	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTGS2—kidney cancer	7.19e-05	0.000366	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PTEN—kidney cancer	6.27e-05	0.000319	CbGpPWpGaD
Nandrolone phenpropionate—CYP19A1—Metabolism—PIK3CA—kidney cancer	4.43e-05	0.000225	CbGpPWpGaD
